The University of Chicago Header Logo

A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer.

A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer. Cancer Chemother Pharmacol. 2002 Jul; 50(1):1-5.

View in: PubMed